Joachim März

Title: Innovations by Joachim März in Integrin Inhibition

Introduction

Joachim März is a notable inventor based in Gross-Gerau, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of integrin inhibitors. His work focuses on compounds that can be utilized in the treatment of various circulatory diseases.

Latest Patents

Joachim März holds a patent for "Chromenone and chromanone derivatives as integrin inhibitors." This invention relates to compounds characterized by a specific formula, which includes various substituents as defined in the claims. These compounds are designed to serve as integrin inhibitors, with potential applications in the prophylaxis and treatment of conditions such as thrombosis, myocardial infarction, coronary heart diseases, arteriosclerosis, osteoporosis, and tumor therapy.

Career Highlights

März is associated with Merck Patent GmbH, where he has been involved in innovative research and development. His expertise in medicinal chemistry has positioned him as a key figure in the advancement of therapeutic agents targeting integrins.

Collaborations

Throughout his career, Joachim März has collaborated with notable colleagues, including Claus Fittschen and Simon Lawrence Goodman. These collaborations have contributed to the successful development of his patented compounds.

Conclusion

Joachim März's work in the field of integrin inhibitors represents a significant advancement in the treatment of circulatory diseases. His innovative approach and collaboration with esteemed colleagues highlight the importance of teamwork in scientific research.